Found: 68
Select item for more details and to access through your institution.
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 8, p. 814, doi. 10.1001/jamaneurol.2024.1961
- By:
- Publication type:
- Article
Frequent detection of IFN-gamma-producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1416074
- By:
- Publication type:
- Article
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 899, doi. 10.1177/13524585231223880
- By:
- Publication type:
- Article
High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 5, p. 490, doi. 10.1001/jamaneurol.2024.0395
- By:
- Publication type:
- Article
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2871, doi. 10.1007/s00415-023-12175-2
- By:
- Publication type:
- Article
Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 726, doi. 10.1177/13524585241238840
- By:
- Publication type:
- Article
Longitudinally extensive posterolateral myelitis revealing invasive CNS aspergillosis in an immunocompetent patient.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 755, doi. 10.1177/13524585231221680
- By:
- Publication type:
- Article
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 3, p. 273, doi. 10.1001/jamaneurol.2023.5566
- By:
- Publication type:
- Article
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 381, doi. 10.1177/13524585231218149
- By:
- Publication type:
- Article
The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years—Protocol, recruitment status, and baseline characteristics.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 216, doi. 10.1177/13524585231223390
- By:
- Publication type:
- Article
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 261, doi. 10.1177/13524585231223069
- By:
- Publication type:
- Article
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-023-01213-x
- By:
- Publication type:
- Article
Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 131, doi. 10.1177/13524585231206218
- By:
- Publication type:
- Article
Relevance of kappa free light chains index in patients with aquaporin‐4 or myelin‐oligodendrocyte‐glycoprotein antibodies.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 9, p. 2865, doi. 10.1111/ene.15897
- By:
- Publication type:
- Article
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2319766, doi. 10.1001/jamanetworkopen.2023.19766
- By:
- Publication type:
- Article
Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1004795
- By:
- Publication type:
- Article
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 270, doi. 10.1177/13524585221134214
- By:
- Publication type:
- Article
Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 1, p. 11, doi. 10.1177/13524585221129472
- By:
- Publication type:
- Article
Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1881, doi. 10.1177/13524585221096975
- By:
- Publication type:
- Article
Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 10, p. 5647, doi. 10.1007/s00415-022-11130-x
- By:
- Publication type:
- Article
Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 6, p. 1719, doi. 10.1111/ene.15285
- By:
- Publication type:
- Article
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1155, doi. 10.1177/13524585211049737
- By:
- Publication type:
- Article
Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparative effectiveness of dimethyl fumarate in multiple sclerosis.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 3, p. 1268, doi. 10.1111/bcp.15071
- By:
- Publication type:
- Article
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2280, doi. 10.1177/13524585211006372
- By:
- Publication type:
- Article
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 10, p. 2025, doi. 10.1002/acn3.51451
- By:
- Publication type:
- Article
Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 10, p. 3461, doi. 10.1111/ene.14612
- By:
- Publication type:
- Article
Human papillomavirus lesions in 16 MS patients treated with fingolimod: Outcomes and vaccination.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1794, doi. 10.1177/1352458521991433
- By:
- Publication type:
- Article
Altered Immune Phenotypes and HLA-DQB1 Gene Variation in Multiple Sclerosis Patients Failing Interferon β Treatment.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.628375
- By:
- Publication type:
- Article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- BMC Medical Research Methodology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12874-021-01285-y
- By:
- Publication type:
- Article
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
- Published in:
- 2021
- By:
- Publication type:
- journal article
COVID-19 infection in NMO/SD patients: a French survey.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.
- Published in:
- Annals of Neurology, 2021, v. 89, n. 1, p. 30, doi. 10.1002/ana.25909
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 936, doi. 10.1177/1352458519849511
- By:
- Publication type:
- Article
Sex effects across the lifespan in women with multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420936166
- By:
- Publication type:
- Article
ndividual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 2, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.
- Published in:
- JAMA Neurology, 2020, v. 77, n. 1, p. 94, doi. 10.1001/jamaneurol.2019.2670
- By:
- Publication type:
- Article